Gaxiola E

Language: Spanish
References: 17
Page: 178-184
PDF size: 178.59 Kb.

ABSTRACT

Advances in the understanding of the role of vulnerable plaque coupled with novel diagnostic and therapeutic approaches create a unique opportunity for cardiovascular events prevention due to rupture of vulnerable plaques. Currently, non-invasive methods do not have enough resolution to identify vulnerable plaques, on the other hand, some invasive methods can define the morphological and anatomic characteristics of vulnerable plaques. These invasive methods include intravascular ultrasound and three dimensional intravascular ultrasound, virtual histology, optical coherence tomography, intravascular magnetic resonance and intracoronary angioscopy. Atherosclerotic plaques causing symptoms require local treatment but the systemic nature of the atherosclerotic process requires global therapeutic approach for the prevention of cardiovascular events.

REFERENCES

1. American Heart Association. Heart Disease and Stroke Statistics 2005 Update. Dallas, TX: American Heart Association 2004.

2. Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, et al: Beyond Restenosis: Five-year clinical outcomes from second-generation coronary stent trials. Circulation 2004; 110: 1226-1230.

3. Glaser R, Seltzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, et al: Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005; 111: 143-149.

4. Falk E: Pathogenesis of Atherosclerosis. J Am Coll Cardiol 2006; 47: C7-C12.

5. Davies JR, Rudd JHF, Weissberg PL, Narula J: Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006; 47: C57-C68.

6. Wilensky RL, Kwon-Song H, Ferrari VA: Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J Am Coll Cardiol 2006; 47: C57-C68.

7. Cordeiro MAS, Lima JAC: Atherosclerotic plaque characterization by multidetector row computed tomography angiography. J Am Coll Cardiol 2006; 47: C40-C47.

8. DeMaria AN, Narula , Mahmud E, Tsimikas S: Imaging vulnerable plaque by ultrasound. J Am Coll Cardiol 2006; 47; C32-C39.

9. Libby P: Act local, act global. Inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol 2005; 45: 1600-02.

10. Kawasaki M, Sano K, Okubo M, et al: Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-53.

11. Ohtani T, Ueda Y, Mizote I, Oyabu J, Okada K, Hirayama A, et al: Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome. J Am Coll Cardiol 2006; 47: 2194-2200.

12. Wilensky RL, Kwon-Song H, Ferrari VA: Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J Am Coll Cardiol 2006; 47: C57-C68.

13. Stamper D, Weissman NJ, Brezinski M: Plaque characterization with optical coherence tomography. J Am Coll Cardiol 2006; 47: C69-C79.

14. Schaar JA, van der Steen AFW, Mastik F, Baldewsing RA, Serruys PW: J Am Coll Cardiol 2006; 47: C86-C91.

15. Naghavi M, John R, Naguib JR, et al: Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv 2003; 59: 52-59.

16. Strauss HW, Mari C, Patt BE, Ghazarossian V: Intravascular radiation detectors for the detection of vulnerable plaque. J Am Coll Cardiol 2006; 47: C97-C100.

17. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonano E, Anemona L, et al: Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree. J Am Coll Cardiol 2005; 45: 1585-93.